Q2 FY26 Quarterly Activities Report and Appendix 4C
Filed with ASX · · 11 pages · English
Vitrafy Life Sciences Ltd. on 6ix
In the deck
Story so far
Earlier from Vitrafy Life Sciences
- Vitrafy Enters Strategic Commercial Agreement with IMV
- IMV Strategic Partnership Investor Presentation
- Q1 FY26 Quarterly Activities Report and Appendix 4C
- FY25 Full Year Results Presentation - Amended
- FY25 Appendix 4E and Annual Report
Later from Vitrafy Life Sciences
- FY26 Appendix 4D and Half Year Report
- FY26 Half Year Results Presentation
- USAISR Completes Phase 2 Platelet Study
- Q3 FY26 Quarterly Activities Report and Appendix 4C
- Final US Army Phase 2 Platelet Results
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences